ALPCO has been serving the needs of clinical researchers and clinical diagnostics labs for over 30 years, and we now offer a broad product menu of proprietary automated sample-to-answer platforms. We’re a global leader in immunodiagnostics and molecular diagnostics, with clinical diagnostic solutions for stool-based gastroenterology, infectious and genetic disease, autoimmune disease, and metabolic disorders.
Featured clinical research and diagnostic specialties
Specialty Allergy
Allergens, pathogens, and foreign particles can exaggerate immune responses. ALPCO offers exclusive platforms and products for the detection of allergen sensitization.
Our automated ELISAs decrease hands-on time, cut costs, and reduce assay variability. Streamline your workflow and empower your staff to increase their productivity.
The Calprotectin Immunoturbidimetric Assay is an in vitro diagnostic particle-enhanced immunoassay intended for use by trained laboratory personnel for the quantitative measurement of fecal calprotectin, a neutrophilic protein that is a marker of intestinal mucosal inflammation, in human stool.
The Allergy Explorer² (ALEX²) is a quantitative test for the measurement of allergen specific IgE (sIgE) to more than 295 allergens and a semi-quantitative test for the measurement of total IgE (tIgE) in human serum, heparin plasma, and sodium citrate plasma.
The ALPCO Pancreatic Elastase (PE) Chemiluminescence ELISA is a chemiluminescent immunoassay for the quantitative determination of pancreatic elastase in human stool. Pancreatic elastase (PE or PE-1) refers to a family of chymotrypsin-like elastases (CELAs), digestive proteases produced by acinar cells in the pancreas. PE is highly stable in the intestinal tract and the concentration of pancreatic elastase in stool correlates well with overall pancreatic enzyme output. Both the CELA3A and CELA3B isoforms of PE can be detected in stool and are detected by the Pancreatic Elastase Chemiluminescence ELISA from ALPCO. FDA Registered. For In Vitro Diagnostic Use.
Key features:
User-friendly workflow featuring ready-to-use standards and controls
Resources to advance your discoveries in Clinical research
Differentiating IBD from IBS with Fecal Calprotectin Testing
In an effort to improve patient care, an increasing number of gastroenterologists are using fecal calprotectin levels as a first step in the diagnosis of IBD versus IBS.
Clinical research in the field of gastroenterology continues to uncover underlying causes of gastrointestinal disease and expand diagnostic tests and treatments.
GeneProof offers technologically advanced real-time PCR kits and user-friendly automated instrument platforms for both nucleic acid extraction and sample-to-answer testing.